Scott Gorenstein, MD
Emergency Medicine · Mineola, NYNPI 1144299686
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Integra Lifesciences Corporation at 38.9% of the total. Reporting peaked in 2021 at $4,713 and has fallen 62.5% since, to $1,767 in 2025. Among emergency medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $58.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$4K
- Organogenesis Inc.$3K
- Smith+Nephew$1K
- Inogen, Inc.$1K
- Tactile Systems Technology Inc$332
- Musculoskeletal Transplant Foundation Inc.$134
- plus $628 from 11 others
Across 26 payments — averaging $12,299 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acell, Inc.$205K
- Convatec Inc.$42K
- KCI USA, Inc.$41K
- Smith+Nephew$26K
- Solventum Corporation$6K
What the payments were for
- Consulting fees$5,72551%
- Travel & lodging$5315%
- Food & beverage$4,88244%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 3 | $4,336 |
| Organogenesis Inc. | 113 | $2,985 |
| Smith+Nephew | 32 | $1,373 |
| Inogen, Inc. | 1 | $1,350 |
| Tactile Systems Technology Inc | 13 | $332 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $134 |
| Avita Medical Americas, LLC | 1 | $132 |
| Misonix Inc | 6 | $124 |
| Next Science LLC | 3 | $70 |
| Convatec Inc. | 2 | $54 |
| AbbVie | 3 | $53 |
| Hydrofera LLC | 3 | $50 |
| Cumberland Pharmaceuticals, Inc. | 3 | $50 |
| Inari Medical, Inc. | 1 | $36 |
| KCI USA, Inc. | 1 | $27 |
| Solventum Corporation | 1 | $23 |
| Kerecis Limited | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL PLUS$4,250
- InogenOne$1,350
- PICO$531
- PERMEADERM$132
- RECELL$132
- Cohealyx$132
- PuraPly$131
- Stravix$125
- Grafix$125
- GrafixPL$125
- PuraPly AM$110
- PURAPLY WOUND MATRIX$109
How this compares
$11,139 in reported general payments places this provider in the 95th percentile of 4,167 emergency medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 33 | $294,097 |
| Cefadroxil | 27 | $1,000 |
| Minocycline Hcl | 38 | $883 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $441 |
| Doxycycline Hyclate | 16 | $266 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $213 |
| Mupirocin | 28 | $210 |
| Levofloxacin | 20 | $117 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $52 |
| Tramadol Hcl | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,373 | $294,09733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,167 emergency medicine providers in New York.
Other emergency medicine in Mineola
- David JanickeWilliamsville$441K
- Joseph BartBuffalo$315K
- Joseph HabbousheNew York$309K
- Adam SingerStony Brook$297K
- Sohan ParekhNew York$174K
- Benjamin AbellaNew York$143K
- David LevineCorning$138K
- Harry KopolovichBronx$131K
- Christopher RaioManhasset$92K
- Robert BiernbaumFairport$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.